CA986926A - Cyclopentane derivatives - Google Patents

Cyclopentane derivatives

Info

Publication number
CA986926A
CA986926A CA145,746A CA145746A CA986926A CA 986926 A CA986926 A CA 986926A CA 145746 A CA145746 A CA 145746A CA 986926 A CA986926 A CA 986926A
Authority
CA
Canada
Prior art keywords
cyclopentane derivatives
cyclopentane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA145,746A
Other versions
CA145746S (en
Inventor
Keith B. Mallion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA986926A publication Critical patent/CA986926A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA145,746A 1971-07-14 1972-06-26 Cyclopentane derivatives Expired CA986926A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3304971 1971-07-14
GB3304971A GB1372541A (en) 1971-07-14 1971-12-16 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
CA986926A true CA986926A (en) 1976-04-06

Family

ID=26261688

Family Applications (1)

Application Number Title Priority Date Filing Date
CA145,746A Expired CA986926A (en) 1971-07-14 1972-06-26 Cyclopentane derivatives

Country Status (12)

Country Link
JP (1) JPS5629665B1 (en)
BE (1) BE786251A (en)
CA (1) CA986926A (en)
CH (1) CH575902A5 (en)
DD (1) DD102141A5 (en)
DE (1) DE2234709C2 (en)
FR (1) FR2145697B1 (en)
GB (1) GB1372541A (en)
HU (1) HU166719B (en)
IE (1) IE36914B1 (en)
NL (1) NL7209817A (en)
SE (2) SE399706B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422369A (en) * 1988-09-06 1995-06-06 Kabi Pharmacia Ab Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension
US5422368A (en) * 1988-09-06 1995-06-06 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113723A (en) 1972-07-13 1978-09-12 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandins
FR2361381A1 (en) * 1972-07-13 1978-03-10 Pfizer (15)-(Hetero) aryl prostaglandin analogues - with long-lasting prostaglandin-like activity
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
HU212570B (en) * 1991-06-24 1996-08-29 Chinoin Gyogyszer Es Vegyeszet Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
WO2004026315A1 (en) * 2002-09-19 2004-04-01 Ilex Oncology Research, Sarl Substituted ketophosphonate compounds having bone anabolic activity
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422369A (en) * 1988-09-06 1995-06-06 Kabi Pharmacia Ab Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension
US5422368A (en) * 1988-09-06 1995-06-06 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5578618A (en) * 1988-09-06 1996-11-26 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5627208A (en) * 1988-09-06 1997-05-06 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5849791A (en) * 1988-09-06 1998-12-15 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6030999A (en) * 1988-09-06 2000-02-29 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6417230B2 (en) 1988-09-06 2002-07-09 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6429226B1 (en) 1988-09-06 2002-08-06 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US7163959B2 (en) 1988-09-06 2007-01-16 Pharmacia Aktiebolag Prostagladin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Also Published As

Publication number Publication date
IE36914L (en) 1973-01-14
NL7209817A (en) 1973-01-16
DD102141A5 (en) 1973-12-05
IE36914B1 (en) 1977-03-30
AU4394072A (en) 1974-01-03
HU166719B (en) 1975-05-28
SE7504707L (en) 1975-04-23
JPS5629665B1 (en) 1981-07-09
FR2145697B1 (en) 1976-04-16
CH575902A5 (en) 1976-05-31
DE2234709C2 (en) 1982-06-03
FR2145697A1 (en) 1973-02-23
BE786251A (en) 1973-01-15
DE2234709A1 (en) 1973-02-01
SE399706B (en) 1978-02-27
GB1372541A (en) 1974-10-30

Similar Documents

Publication Publication Date Title
CA979436A (en) Cyclopentane derivatives
AU462755B2 (en) Cyclopentane derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
CA986926A (en) Cyclopentane derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
AU461957B2 (en) Lumilysergol derivatives
AU461617B2 (en) Cyclopentane derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU463679B2 (en) Dibenzocycloheptadioxolan derivatives
AU470552B2 (en) Aminocephalosporin derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
AU468572B2 (en) Cyclopentane derivatives
CA867769A (en) Fluoracylamino-trichloromethyl-methane derivatives
CA862773A (en) N-phenylsuccinimide derivatives
AU463550B2 (en) Nitrofurylpyrimidine derivatives
CA862754A (en) Benzothiazepin-4-one derivatives
AU458249B2 (en) Tropan-3-ol derivatives
CA919667A (en) Carbonyldioxymorphinan derivatives
CA871716A (en) Norscopolamine derivatives
AU479054B2 (en) Triazole-ethenyl-phenylene derivatives
AU475768B2 (en) Ergolene derivatives
AU475691B2 (en) 7-amino-indazole derivatives
CA869544A (en) Thieno-benzothiazine derivatives
CA872254A (en) Indenopyridine derivatives
CA872252A (en) 4-substituted-benzocyclohepta-imidazole derivatives